Strategies for targeted nonviral delivery of siRNAs in vivo

被引:90
作者
Kim, Sang-Soo [1 ]
Garg, Himanshu [1 ]
Joshi, Anjali [1 ]
Manjunath, N. [1 ]
机构
[1] Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Biomed Sci,Ctr Excellence Infect Dis, El Paso, TX 79905 USA
关键词
SMALL INTERFERING RNA; INHIBITS TUMOR-GROWTH; GENE-THERAPY; CELLULAR UPTAKE; PROTECTS MICE; SYSTEM; CELLS; POLYETHYLENIMINE; THERAPEUTICS; MOUSE;
D O I
10.1016/j.molmed.2009.09.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Silencing specific gene expression by RNA interference (RNAi) has rapidly become a standard tool for the reverse genetic analysis of gene functions. It also has tremendous potential for managing diseases for which effective treatment is currently unavailable or suboptimal. However, the poor cellular uptake of synthetic small interfering RNAs (siRNAs) is a major impediment for their clinical use. Great progress has been made in recent years to overcome this barrier, and several methods have been described for the in vivo delivery of siRNA. Moreover, the latest advances have focused on achieving targeted siRNA delivery restricted to relevant tissues and cell types in vivo. These approaches are expected to reduce the dose requirement as well as minimize siRNA-induced toxicities, thereby advancing the field of siRNA therapy towards clinical use.
引用
收藏
页码:491 / 500
页数:10
相关论文
共 81 条
[1]   RNAi therapeutics: Principles, prospects and challenges [J].
Aagaard, Lars ;
Rossi, John J. .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (2-3) :75-86
[2]   Nonviral delivery of synthetic siRNAs in vivo [J].
Akhtar, Saghir ;
Benter, Ibrahim F. .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (12) :3623-3632
[3]   A combinatorial library of lipid-like materials for delivery of RNAi therapeutics [J].
Akinc, Akin ;
Zumbuehl, Andreas ;
Goldberg, Michael ;
Leshchiner, Elizaveta S. ;
Busini, Valentina ;
Hossain, Naushad ;
Bacallado, Sergio A. ;
Nguyen, David N. ;
Fuller, Jason ;
Alvarez, Rene ;
Borodovsky, Anna ;
Borland, Todd ;
Constien, Rainer ;
de Fougerolles, Antonin ;
Dorkin, J. Robert ;
Jayaprakash, K. Narayanannair ;
Jayaraman, Muthusamy ;
John, Matthias ;
Koteliansky, Victor ;
Manoharan, Muthiah ;
Nechev, Lubomir ;
Qin, June ;
Racie, Timothy ;
Raitcheva, Denitza ;
Rajeev, Kallanthottathil G. ;
Sah, Dinah W. Y. ;
Soutschek, Juergen ;
Toudjarska, Ivanka ;
Vornlocher, Hans-Peter ;
Zimmermann, Tracy S. ;
Langer, Robert ;
Anderson, Daniel G. .
NATURE BIOTECHNOLOGY, 2008, 26 (05) :561-569
[4]   Formulation and Delivery of siRNA by Oleic Acid and Stearic Acid Modified Polyethylenimine [J].
Alshamsan, Aws ;
Haddadi, Azita ;
Incani, Vanessa ;
Samuel, John ;
Lavasanifar, Afsaneh ;
Uludag, Hasan .
MOLECULAR PHARMACEUTICS, 2009, 6 (01) :121-133
[5]   Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation [J].
Aouadi, Myriam ;
Tesz, Gregory J. ;
Nicoloro, Sarah M. ;
Wang, Mengxi ;
Chouinard, My ;
Soto, Ernesto ;
Ostroff, Gary R. ;
Czech, Michael P. .
NATURE, 2009, 458 (7242) :1180-U116
[6]   Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small RNAs [J].
Babiarz, Joshua E. ;
Ruby, J. Graham ;
Wang, Yangming ;
Bartel, David P. ;
Blelloch, Robert .
GENES & DEVELOPMENT, 2008, 22 (20) :2773-2785
[7]   Tf-lipoplexes for neuronal siRNA delivery: A promising system to mediate gene silencing in the CNS [J].
Cardoso, A. L. C. ;
Simoes, S. ;
de Almeida, L. P. ;
Plesnila, N. ;
Pedroso de Lima, M. C. ;
Wagner, E. ;
Culmsee, C. .
JOURNAL OF CONTROLLED RELEASE, 2008, 132 (02) :113-123
[8]   The promises and pitfalls of RNA-interference-based therapeutics [J].
Castanotto, Daniela ;
Rossi, John J. .
NATURE, 2009, 457 (7228) :426-433
[9]   Neovascular age-related macular degeneration - Potential therapies [J].
Chappelow, Aimee V. ;
Kaiser, Peter K. .
DRUGS, 2008, 68 (08) :1029-1036
[10]   A crucial test [J].
Check, E .
NATURE MEDICINE, 2005, 11 (03) :243-244